Anti-HSD17B1 antibody [EP1682Y]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(20 Publications)
Rabbit Recombinant Monoclonal HSD17B1 antibody. Suitable for IHC-P, IP, WB, Flow Cyt (Intra) and reacts with Human samples. Cited in 20 publications.
View Alternative Names
E17KSR, EDH17B1, EDH17B2, EDHB17, SDR28C1, HSD17B1, 17-beta-hydroxysteroid dehydrogenase type 1, 17-beta-HSD 1, 20 alpha-hydroxysteroid dehydrogenase, E2DH, Estradiol 17-beta-dehydrogenase 1, Placental 17-beta-hydroxysteroid dehydrogenase, Short chain dehydrogenase/reductase family 28C member 1, 20-alpha-HSD
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-HSD17B1 antibody [EP1682Y] (AB51045)
Overlay histogram showing JEG3 cells stained with ab51045 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab51045, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-rabbit IgG (H+L) (ab96899) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (1μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HSD17B1 antibody [EP1682Y] (AB51045)
ab51045 (1/100 dilution) staining human HSD17B1 in paraffin embedded human placenta tissue by Immunohistochemistry.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IP
Lab
Immunoprecipitation - Anti-HSD17B1 antibody [EP1682Y] (AB51045)
Purified ab51045 at 1/50 dilution (2μg) immunoprecipitating HSD17B1 in Human placenta lysate.
Lane 1 (input) : Human placenta lysate 10μg
Lane 2 (+) : ab51045 + Human placenta lysate.
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab51045 in Human placenta lysate.
VeriBlot for IP Detection Reagent (HRP) (ab131366) (1/1000 dilution) was used for Western blotting.
Blocking Buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM/TBST.
Observed band size : 34 kDa
All lanes:
Immunoprecipitation - Anti-HSD17B1 antibody [EP1682Y] (ab51045)
Predicted band size: 35 kDa
false
- WB
Unknown
Western blot - Anti-HSD17B1 antibody [EP1682Y] (AB51045)
All lanes:
Western blot - Anti-HSD17B1 antibody [EP1682Y] (ab51045) at 1/100000 dilution
All lanes:
Human placenta tissue lysate at 10 µg
Secondary
All lanes:
Goat anti-Rabbit HRP labeled at 1/2000 dilution
Predicted band size: 35 kDa
Observed band size: 35 kDa
false
- WB
CiteAb
Western blot - Anti-HSD17B1 antibody [EP1682Y] (AB51045)
HSD17B1 western blot using anti-HSD17B1 antibody [EP1682Y] ab51045. Publication image and figure legend from Aka, J. A., Zerradi, M., et al., 2012, Breast Cancer Res, PubMed 22691413.
ab51045 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab51045 please see the product overview.
Proteomic analysis of wild type (WT) MCF7 cells and MCF7 cells stably transfected with 17β-HSD1 (MCF7-17βHSD1). (A) 17beta-hydroxysteroid dehydrogenase type 1 (17β-HSD1) and β-actin expression between WT MCF7 and MCF7-17βHSD1 revealed by western blots. (B) Representative two-dimensional gel images for WT MCF7 and MCF7-17βHSD1 cells. Whole cell lysates (200 μg) from each cell were separated by two-dimensional electrophoresis and visualized by Sypro Ruby staining. The two-dimensional gels were scanned and the differentially expressed (2-fold or higher, p < 0.05) proteins were detected using Progenesis software. The 18 differentially expressed protein spots that were selected for mass spectrometry (MS) analysis are marked with circles. Protein spots upregulated in MCF7-17βHSD1 are depicted in the MCF7-17βHSD1 proteome image; protein spots downregulated in MCF7-17βHSD1 are depicted in the MCF7 proteome image. The numbers refer to the spot number listed in Table 1 and Additional file 2. The squares represent the indicated area shown in more detail in (D). (C) Summary of the numbers of spots and proteins obtained from the proteomics data. *Upregulated (up) and downregulated (down) proteins in MCF7-17βHSD1 as compared to WT MCF7 cells. (D) Zoom showing some differentially expressed protein spots from WT MCF7 and MCF7-17βHSD1 comparison. Arrows indicate 17β-HSD1 protein which was revealed by MS analysis to be present in the spot numbers 2,305 (unique to MCF7-17βHSD1) and 2,300 (upregulated in MCF7-17βHSD1 as compared to WT MCF7 cells).
false
Related conjugates and formulations (1)
-
Anti-HSD17B1 antibody [EP1682Y] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (20)
Recent publications for all applications. Explore the full list and refine your search
Biomolecules 14: PubMed39199376
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in endocrinology 14:1268248 PubMed37964966
2023
Applications
Unspecified application
Species
Unspecified reactive species
Reproductive biology and endocrinology : RB&E 20:126 PubMed35986324
2022
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of clinical endocrinology and metabolism 107:e3374-e3383 PubMed35511085
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in molecular biosciences 9:854991 PubMed35591944
2022
Applications
Unspecified application
Species
Unspecified reactive species
Methods and protocols 5: PubMed35448699
2022
Applications
Unspecified application
Species
Unspecified reactive species
Reproductive biology and endocrinology : RB&E 18:119 PubMed33225937
2020
Applications
Unspecified application
Species
Unspecified reactive species
Nanomaterials (Basel, Switzerland) 10: PubMed32635405
2020
Applications
Unspecified application
Species
Unspecified reactive species
Placenta 83:57-62 PubMed31477209
2019
Applications
Unspecified application
Species
Unspecified reactive species
Drug design, development and therapy 13:757-766 PubMed30863015
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com